Prophylactic cranial irradiation versus observation in stage III non-small-cell lung cancer

Clinical Lung Cancer

Volumn 7, Issue 4, 2006, Pages 276-278

  Gore, Elizabeth ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; BRAIN RADIATION; BRAIN RADIOGRAPHY; CANCER INCIDENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE EXACERBATION; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MULTIMODALITY CANCER THERAPY; NEUROPSYCHOLOGICAL TEST; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 33244479683     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-7304(11)70694-5     Document Type: Note

References (30)

1. Furuse K, Kubota K, Kawahara M, et al. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group. J Clin Oncol 1995; 13(4):869-875.
2. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13:1880-1892.
3. Stuschke M, Eberhardt, Pottgen C, et al. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment: long-term followup and investigations of late neuropsychologic effects. J Clin Oncol 1999; 17:2700-2709.
4. Strauss GM, Herndon JE, Sherman DD, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992; 10: 1237-1244.
5. Cox JD, Stanley K, Petrovich Z, et al. Cranial irradiation in cancer of the lung of all cell types. JAMA 1981; 245:469-472.
6. Russell AH, Pajak TE, Selim HM, et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Rad Onc Biol Phys 1991; 21:637-643.
7. Umsawasdi T, Valdivieso, M, Chen TT, et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol 1984; 2:253-259.
8. Skarin A, Jochelson M, Sheldon T, et al. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-smail cell lung cancer: long-term follow-up in 41 patients. J Surg Onc 1989; 40:266-274.
9. Robnett TJ, Machtay M, Stevenson JP, et al. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol 2001; 19:1344-1349.
10. Law A, Karp DD, Dipetrill T, et al. Emergence of increased cerebral metasmsis after preoperative radiotherapy with chemotherapy in patients with locally advanced non-small cell lung carcinoma. Cancer 2001; 92:160-164.
11. Ceresoli GL, Reni M, Chiesa G, et al. Brain metastases in locally advanced non-small cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 2002; 95:605-612.
12. Andre F. Grunenwald D, Pujol JL, et al. Patterns of relapse of N2 non-small-cell lung carcinoma patients treated with preoperative chemotherapy. Cancer 2001; 91:2394-2400.
13. Gaspar LE, Chansky K, Albain KS, et al. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small cell lung cancer: a retrospective review by the Southwest Ontology Group. J Clin Oncol 2005; 23:2955-2961.
14. Carolan H, Sun AY, Bezjak A, et al. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? Lung Cancer 2005; 49:109-115.
15. Mamon HJ, Yeap BY, Janne PA, et al. High risk of brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 2005; 23:1530-1537.
16. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Rad Onc Biol Phys 1997; 37:745-751.
17. Choi NC, Carey RW, Daly W, et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 1997; 15:712-722.
18. Cox JD, Scott CB, Byhardt RW, et al. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of Radiation Therapy Oncology Group (RTOG) trials. Int J Rad Onc 1999; 43:505-509.
19. Perez CA, Pajak TF, Simpson JR, et al. Long-term observations of the patterns of failore in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987; 59:1874-1881.
20. Komaki R, Scott CB, Byhardt R, et al. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four Radiation Therapy Oncology Group (RTOG) studies in inoperable non-small-cra lung cancer. Int J Rad Onc Biol Phys 1998; 42:263-267.
21. Keith B, Vincent M, Statt L, et al. Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung caner. Am J Clin Oncol 2002; 25:583-587.
22. Yokoi K, Kamiya N, Matsuguama H, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer. A comparison of CT and MRI. Chest 1999; 115:714-719.
23. Rusch VW, Griffin BR, Livingston RB. The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwestern Oncology Group Study. J Thorac Cardiovasc Surg 1989; 98:535-539.
24. Jacobs RH, Awan A, Bitran JD, et al. Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role. Cancer 1987; 59:2016-2019.
25. Johnson BE, Becker B, Goff WB, et al. Neurologic, neuropsychologic, and computer 4d cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer. J Clin Oncol 1985; 3:1659-1667.
26. Komaki R. Neurological sequelae in long-term survivors of small cell lung cancer. Int J Rad Onc Biol Phys 1996; 34:1181-1183.
27. Lester JF, Macbeth FR, Coles B. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer: a Cochrane review. Int J Rad Onc Biol Phys 2005; 63:690-694.
28. Cho LC, Dowell JE, Garwood D, et al. Prophylactic cranial irradiation with combined modality therapy for patients with locally advanced non-small cell lung cancer. Semin Oncol 2005; 32:293-298.
29. Westeel V. Risk of brain metastases in non-metastatic non-small cell lung cancer. Lung Cancer 2003; 41 (suppl 2):21.
30. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322:494-500.